Twist bioscience corp (TWST)
Income statement / Yearly
Sep'19Sep'18Sep'17
Revenues

54,385

25,427

10,767

Operating expenses:
Cost of revenues

47,426

32,189

24,020

Research and development

35,683

20,347

19,169

Selling, general and administrative

80,126

43,450

26,060

Total operating expenses

163,235

95,986

69,249

Loss from operations

-108,850

-70,559

-58,482

Interest income

3,032

999

412

Interest expense

1,294

1,313

905

Other income (expense), net

-265

-121

-55

Loss before income taxes

-107,377

-70,994

-59,030

Provision for income taxes

292

242

280

Net loss attributable to common stockholders

-107,669

-71,236

-59,310

Other comprehensive loss:
Change in unrealized gain on investments

49

-

-9

Foreign currency translation adjustment

45

54

33

Comprehensive loss

-107,575

-71,182

-59,286

Net loss per share attributable to common stockholders—basic and diluted

-3.92

-25.51

-24.49

Weighted average shares used in computing net loss per share attributable to common stockholders—basic and diluted

27,461,844

2,792,743

2,422,243